(Stroke. 1996;27:276-281.)
© 1996 American Heart Association, Inc.
Articles |
Presented in part at the Congress of Neurological Surgeons, San Francisco, Calif, October 14-19, 1995.
From the Departments of Anesthesiology (J.B.S., A.J.L., T.J.G.), Medicine (A.J.L.), Neurosurgery (J.B.S., A.L.D.), and Surgery (T.J.G., A.J.L.), University of Florida College of Medicine (Gainesville).
Correspondence to Editorial Office, A.J. Layon, MD, Department of Anesthesiology, University of Florida College of Medicine, Box 100254, Gainesville, FL 32610-0254. E-mail edit.anest2@wpo.health.ufl.edu.
| Abstract |
|---|
|
|
|---|
Methods Patients (n=219) who underwent
craniotomy for intracranial aneurysm and SAH
over 6 years at one tertiary care center were divided in two ways by
age: single advanced age (<65 years and
65 years) and decade of age
(23 to 39, 40 to 49, 50 to 59, 60 to 69, and 70 to 81 years). Data
recorded for each patient included numbers of procedures and
complications in the surgical intensive care unit (SICU), number of
days in the SICU and the hospital, costs for SICU and ward care, total
cost (SICU plus ward costs), and the Acute Physiology and Chronic
Health Evaluation (APACHE) II score at admission and discharge, the
Hunt-Hess grade at admission and immediately preoperatively, and
quality of life score, a measure of outcome. Mortality rates by age
group were calculated.
Results The only variable significantly affected by
decade of age was mortality rate, which increased as decade of age
increased (3% to 17%). With the 65-year comparison, mortality rate,
cost, APACHE II score at admission and discharge, days before
operation, and days in the SICU were significantly higher for age
65
years.
Conclusions Whereas mortality is higher for the older age group, quality of life scores appear acceptable for those who survive. Even though the hospital costs of treating elderly patients for SAH may be higher than those for younger patients, this should not be used to justify withholding care from the elderly.
Key Words: aged craniectomy costs and cost analysis quality of life subarachnoid hemorrhage
| Introduction |
|---|
|
|
|---|
| Subjects and Methods |
|---|
|
|
|---|
65 years
(AGE
65); and (2) decade of age, 23 to 39
years of age (AGE<40), 40 to 49 years (AGE40),
50 to 59 years (AGE50), 60 to 69 years (AGE60),
and 70 to 81 years (AGE
70). The study
consisted of a combined prospective/retrospective analysis.
Contemporaneously collected data were age, sex, race, diagnoses on
admission to the hospital and SICU, sequential APACHE II scores,
discharge status, and numbers of complications, procedures, and days in
the SICU. Retrospectively collected data were location of
aneurysm, incidence of ventriculotomy-dependent
hydrocephalus, and costs of SICU and non-SICU care and combined cost.
Each patient's condition and outcome were scored in three ways. Two
measures of morbidity were used. For severity of illness, APACHE II
scores at admission and at discharge from the SICU were
recorded.7 For severity of neurological insult, HH
grade8 at admission and immediately before operation was
recorded as follows: grade 0, no hemorrhage,
asymptomatic aneurysm; grade 1, SAH with no
neurological deficit, possible nuchal rigidity and headache; grade 2,
moderate to severe headache, nuchal rigidity, no neurological deficit
other than cranial nerve palsy; grade 3, drowsiness, confusion, or mild
focal deficit; grade 4, stupor, moderate to severe hemiparesis, and
possibly early decerebrate rigidity and vegetative
disturbances; and grade 5, coma, decerebrate rigidity, and
moribund appearance. Outcome was assessed by QOL score as follows: grade 1, normal lifestyle or a return to that before SAH; grade 2, minor neurological dysfunction but activities of daily living can be performed without help; grade 3, needs help with some activities of daily living; grade 4, unable to perform activities of daily living and requires full-time care, eg, in a rehabilitation center; and grade 5, death.
Mortality rate was calculated for each age group.
With a computerized statistical analysis system (SigmaStat
version 1.01, Jandel Corp), all data were evaluated for normality of
distribution. Continuous data not normally distributed were
analyzed by Mann-Whitney rank sum, Wilcoxon signed
rank, and Kruskal-Wallis tests. Normally distributed data were
analyzed by the unpaired t test. APACHE II and HH
scores on admission, before operation, and at discharge were evaluated
with ANOVA. All costs and durations of care were treated as
nonrepeated measures in each population and were analyzed
with the Mann-Whitney rank sum test. Proportional data, such as QOL
score, were analyzed with either the
2 or
the Fisher's exact test. Multiple regression analysis was used
to determine which variable or group of variables most closely
correlated with QOL score. Statistical significance was set at
P
.05.
| Results |
|---|
|
|
|---|
|
|
|
Duration of SICU care, which ranged from 4 to 10.5 days, did not differ
by decade of age; however, with the 65-year-based division,
AGE
65 had significantly more SICU days than
AGE<65 (Table 4
). Number of
days in the SICU before surgery was significantly higher in
AGE60 than the two youngest groups and than the oldest
group (5 versus 2 days). This difference in SICU days before surgery
also occurred in the 65-year-based groups (2 versus 3 days,
P=.017). Number of procedures and complications in the SICU
did not differ by age group (Table 4
). Cost was significantly
greater
for AGE
65 (Table 4
); costs tended to increase
as decade of age increased, but this did not achieve statistical
significance.
|
Morbidity and Outcome
APACHE II scores were significantly
higher in most older groups
compared with younger groups at admission and discharge (Table
4
); this
was true for both the decade and 65-year comparisons. On admission and
immediately before surgery, HH grade did not differ significantly by
age (Table 4
). Compared with AGE<65, the
AGE
65 group had a significantly higher
mortality (13% versus 4.6%) and QOL score (2 versus 1) (Table
4
).
Mortality by decade ranged from 3% to 17%, the only significant
difference occurring between AGE50 and
AGE
70 (Table 4
).
Power analysis suggested
that each group contained a sufficient
number of patients to show differences in outcome if they existed.
Although analysis showed that mortality rate increased with
AGE
70, both mean and median morbidity
statistics failed to differ between any age groups except
AGE50 and AGE
70 (Table 4
). The
final HH gradeweighted QOL showed that higher HH grade at
admission, regardless of age, was significantly associated with higher
QOL score (P
.05).
Multiple linear regression was performed on the following variables to evaluate their impact on QOL outcome and thus their impact on outcome: age, number of days between hemorrhage and surgery, HH grade on admission and just before surgery, APACHE II score on admission and discharge, non-SICU and SICU costs, and days and number of complications and procedures in the SICU. Only about 35% of the variation in outcome could be accounted for by these variables (r=.592, r2=.35).
| Discussion |
|---|
|
|
|---|
Studies have reported that the incidence of SAH increases with
age.6 20 Even before those studies, however, it
seemed
intuitive that older patients must necessarily have a worse outcome
secondary to comorbidity. If this were true, then what age group has
the greatest surgical risk or at what age does risk begin to become
"greater"? Several large studies have compared patients by age in
an attempt to answer this question (Table 5
). In
general, patients with higher HH grade and significant underlying
medical problems do worse than those without these risk factors. Even
though early
studies1 4 5 15 19
suggested that age was an
independent risk factor for worse outcome, better data now
available2 6 18 21 indicate
that surgical outcome for
elderly patients is not necessarily poor. Functional status at 6 months
to 1 year does appear to worsen with HH grade and age.
|
As several other investigators have
done,1 2 4 6 15 18 21
we also examined the effect of clinical grade in the present study.
Although scoring systems have flaws11 when used for
predictive purposes, as has occurred with the APACHE II system, these
systems can provide an objective barometer of the degree of
comorbidity. Clinical grade as represented by HH score did
not differ by age, which suggests that the severity of the SAH was a
more important determinant than age. APACHE II scores, however, did
vary by age: they were higher both at admission and at discharge with
AGE
65 and were higher for the two older
decade groups compared with the two younger decade groups. Therefore,
it was surprising that number of complications or duration of
hospitalization did not differ by age. This emphasizes that, while risk
related to comorbidity can be greater for the elderly, this is not a
given.
With the onset of managed care, concern with cost-effectiveness in
health care has increased.12 We wanted to determine
whether our elderly patients were in fact more expensive to treat and
whether outcome was significantly worse. Cost was, indeed,
significantly higher in every area of care for
AGE
65 than AGE<65 (Table 4
);
when evaluated by decade, however, there were no significant cost
differences.
In the comparison by decade of age, mortality was increased in a
clinically significant manner only with the oldest age group and in the
overall comparison (Table 4
). Outcome also worsened with age;
however,
this difference is unlikely to be clinically significant. All of the
older patients remained independent and able to continue to perform the
activities of daily living.
Although mortality in our study was low and outcome generally excellent compared with the results reported in many previous studies, neurosurgeons may nonetheless need to reassess their understanding of a "good" outcome. Previous studies have primarily based evaluation of surgical results on mortality and some determinant of functional status, such as the Glasgow Coma Scale or QOL. Recently, more sophisticated neuropsychological testing has shown that patients previously considered to have had a good outcome in fact have significant impairment of cognitive function.22 23 For example, nonverbal memory deficits can be frequent, severe, and persistent, with 47% of patients having moderate-to-severe impairment 1 year after craniotomy for aneurysmal SAH.23 Problems with speed of response and visuospatial and frontal lobe abilities occurred and were more profound in the elderly, which suggests that they suffered greater long-term effects from SAH. These data, combined with the fact that fewer than 50% of those who suffer SAH return to work, suggest that tremendous work remains to be done in the treatment and rehabilitation of persons who suffer SAH.
We think that the results from our study combined with other recent findings18 suggest that elderly patients, certainly those older than 65 years, can benefit from aggressive treatment. Although mortality is worse for older patients, outcome of patients who survive is acceptable (data on cognitive impairment23 notwithstanding). Many of these patients will require rehabilitation but can, with aggressive postoperative care, continue to lead useful and productive lives. Thus, the analysis of data from our institution indicates that aggressive treatment of the elderly is appropriate unless and until the patient or family/surrogate determines that, for nonmedical reasons, nonsurgical treatment is preferred. Finally, even though the hospital costs for treating SAH may be higher in elderly patients, whether access to care should be based on the cost of care provision is a moral and ethical question and is not answerable strictly by accounting principles.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received September 1, 1995; revision received November 1, 1995; accepted November 1, 1995.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D J Nieuwkamp, G J E Rinkel, R Silva, P Greebe, D A Schokking, and J M Ferro Subarachnoid haemorrhage in patients >=75 years: clinical course, treatment and outcome J. Neurol. Neurosurg. Psychiatry, August 1, 2006; 77(8): 933 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lubicz, X. Leclerc, J.-Y. Gauvrit, J.-P. Lejeune, and J.-P. Pruvo Endovascular Treatment of Ruptured Intracranial Aneurysms in Elderly People AJNR Am. J. Neuroradiol., April 1, 2004; 25(4): 592 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vogel, R. Verreault, J.-F. Turcotte, M. Kiesmann, and M. Berthel Review Article. Intracerebral Aneurysms: A Review With Special Attention to Geriatric Aspects J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2003; 58(6): M520 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sedat, M. Dib, M. Lonjon, S. Litrico, D. Von Langsdorf, D. Fontaine, and P. Paquis Endovascular Treatment of Ruptured Intracranial Aneurysms in Patients Aged 65 Years and Older: Follow-Up of 52 Patients After 1 Year Stroke, November 1, 2002; 33(11): 2620 - 2625. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Johansson, K. G. Cesarini, C. F. Contant, L. Persson, and P. Enblad Changes in Intervention and Outcome in Elderly Patients With Subarachnoid Hemorrhage Stroke, December 1, 2001; 32(12): 2845 - 2949. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Reed, D. K. Blough, K. Meyer, and J. G. Jarvik Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals Neurology, July 24, 2001; 57(2): 305 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Lempert, A. M. Malek, V. V. Halbach, C. C. Phatouros, P. M. Meyers, C. F. Dowd, and R. T. Higashida Endovascular Treatment of Ruptured Posterior Circulation Cerebral Aneurysms : Clinical and Angiographic Outcomes Stroke, January 1, 2000; 31(1): 100 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Johnston, D. R. Gress, and J. G. Kahn Which unruptured cerebral aneurysms should be treated?: A cost-utility analysis Neurology, June 1, 1999; 52(9): 1806 - 1806. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |